AFR vs Burkina Faso: Meningococcal A conjugate (MENGA) vaccine immunization coverage (%)
AFR
27.0%
in 2025
Burkina Faso
66.0%
in 2025
AFR rank
5th
Burkina Faso rank
7th
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) over time
- AFR
- Burkina Faso
How they compare
Burkina Faso currently reports 66.0% against 27.0% in AFR, a difference of 39.0%.
That makes Burkina Faso's figure about 2.4 times AFR's.
Across all 10 years both countries report, Burkina Faso has been ahead every year.
AFR ranks 5th and Burkina Faso ranks 7th of 7 groups.
Burkina Faso has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | AFR | Burkina Faso | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8.8% | 52.2% | 43.5% | Burkina Faso |
| 2020s | 25.7% | 68.0% | 42.3% | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher meningococcal a conjugate (menga) vaccine immunization coverage (%), AFR or Burkina Faso?
- Burkina Faso, at 66.0% against 27.0% in AFR as of 2025.
- What is the difference in meningococcal a conjugate (menga) vaccine immunization coverage (%) between AFR and Burkina Faso?
- 39.0%, with Burkina Faso ahead.
- How many years of comparable data are there for AFR and Burkina Faso?
- 10 years are reported by both, from 2016 to 2025.
- How do AFR and Burkina Faso rank globally for meningococcal a conjugate (menga) vaccine immunization coverage (%)?
- AFR ranks 5th and Burkina Faso ranks 7th of 7 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.